CD19+ B-Cells, a New Biomarker of Mortality in Hemodialysis Patients.

about

CD19+ B-Cells, a New Biomarker of Mortality in Hemodialysis Patients.

Item

http://www.wikidata.org/entity/Q55408845

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

CD19+ B-Cells, a New Biomarker of Mortality in Hemodialysis Patients.

@en

CD19+ B-Cells, a New Biomarker of Mortality in Hemodialysis Patients.

@nl

type

Item

label

CD19+ B-Cells, a New Biomarker of Mortality in Hemodialysis Patients.

@en

CD19+ B-Cells, a New Biomarker of Mortality in Hemodialysis Patients.

@nl

prefLabel

CD19+ B-Cells, a New Biomarker of Mortality in Hemodialysis Patients.

@en

CD19+ B-Cells, a New Biomarker of Mortality in Hemodialysis Patients.

@nl

P1476

CD19+ B-Cells, a New Biomarker of Mortality in Hemodialysis Patients

@en

P2093

Cristina Fernández

http://www.w3.org/2001/XMLSchema#string

Daniel E Pleguezuelo

http://www.w3.org/2001/XMLSchema#string

Eduardo Gutiérrez

http://www.w3.org/2001/XMLSchema#string

Eduardo R Hernández

http://www.w3.org/2001/XMLSchema#string

Francisco Ríos

http://www.w3.org/2001/XMLSchema#string

Luis E Ramos

http://www.w3.org/2001/XMLSchema#string

Luis M Allende

http://www.w3.org/2001/XMLSchema#string

Manuel Praga

http://www.w3.org/2001/XMLSchema#string

P2860

Targeting B cells in atherosclerosis: closing the gap from bench to bedside

Immune dysfunction in uremia—an update

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

B cell subsets in atherosclerosis.

Disturbances of acquired immunity in hemodialysis patients.

Effect of end-stage renal disease on B-lymphocyte subpopulations, IL-7, BAFF and BAFF receptor expression.

Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome).

Molecular aspects of T- and B-cell function in uremia.

Inflammation in end-stage renal disease: sources, consequences, and therapy.

Lymphocyte migration into atherosclerotic plaque.

P304

1221

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FIMMU.2018.01221

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Enrique Morales

M Molina

P577

2018-06-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29963040

http://www.w3.org/2001/XMLSchema#string

P921

biomarker

P932

6013647

http://www.w3.org/2001/XMLSchema#string